Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Gross-Profit" stands at 62.73 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 03/31/2023.
Johnson & Johnson's third quarter result of 16.69 Billion USD for the item "Gross Profit" represents an increase of 3.57 percent compared to it's second quarter result.
Also, Johnson & Johnson's third quarter result of 16.69 Billion USD for the item "Gross Profit" represents an increase of 7.62 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of 62.73 Billion USD for the item "Gross Profit" represents an increase of 1.92 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.60 percent compared to the value the year prior.
The 1 year change in percent is 3.60.
The 3 year change in percent is -3.13.
The 5 year change in percent is 18.12.
The 10 year change in percent is 28.55.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Gross Profit | 905,699,262,464.00 |
![]() | AbbVie Inc - Gross Profit | 399,570,305,024.00 |
![]() | Roche Holding AG - Gross Profit | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Gross Profit | 280,205,508,085.11 |
![]() | Novartis AG - Gross Profit | 255,096,620,580.91 |